Finance

Lists
Why is TATVA down 2,05%?
Dive Deeper
TATVA:NSE
Tatva Chintan Pharma Chem Ltd
₹1 817,50
-2,05%
(-38,10) 1D
9 Okt., 11:27:53 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for TATVA...
Open
₹1 850,10
High
₹1 880,90
Low
₹1 810,00
Mkt. cap
42,52 mjd
Avg. vol.
79,20 k
Volume
36,57 k
Dividend
0,11%
Quarterly dividend
₹0,50
Ex-dividend date
11 Sep. 2026
P/E ratio
82,73
52-wk high
₹2 008,70
52-wk low
₹1 040,30
EPS
₹21,97
No. of employees
793
Open
₹1 850,10
High
₹1 880,90
Low
₹1 810,00
Mkt. cap
42,52 mjd
Avg. vol.
79,20 k
Volume
36,57 k
Dividend
0,11%
Quarterly dividend
₹0,50
Ex-dividend date
11 Sep. 2026
P/E ratio
82,73
52-wk high
₹2 008,70
52-wk low
₹1 040,30
EPS
₹21,97
No. of employees
793
News stories
From web sources and news partners
About Tatva Chintan Pharma Chem Ltd
CEO-
Employees793
Founded1996
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,24 mjd
1,31 mjd
1,34 mjd
1,67 mjd
Cost of goods sold
548,62 m
551,45 m
667,56 m
752,91 m
Cost of revenue
548,62 m
551,45 m
667,56 m
752,91 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
149,47 m
168,24 m
187,87 m
167,36 m
Operating expense
554,92 m
597,72 m
462,20 m
700,34 m
Total operating expenses
1,10 mjd
1,15 mjd
1,13 mjd
1,45 mjd
Operating income
131,62 m
164,17 m
211,68 m
217,30 m
Other non operating income
10,08 m
17,34 m
-32,86 m
27,80 m
EBT including unusual items
136,63 m
176,58 m
168,48 m
211,11 m
EBT excluding unusual items
136,63 m
176,58 m
168,77 m
224,29 m
Income tax expense
37,46 m
24,93 m
65,27 m
51,30 m
Effective tax rate
27,42%
14,12%
38,74%
24,30%
Other operating expenses
314,92 m
338,80 m
176,78 m
427,32 m
Net income
99,17 m
151,65 m
103,21 m
159,81 m
Net profit margin
8,03%
11,55%
7,69%
9,57%
Earnings per share
4,24
6,49
4,41
7,26
Interest and investment income
-
-
4,52 m
-
Interest expense
-5,07 m
-4,93 m
-12,05 m
-20,81 m
Net interest expenses
-5,07 m
-4,93 m
-7,53 m
-20,81 m
Depreciation and amortization charges
90,53 m
90,68 m
97,55 m
105,66 m
EBITDA
221,74 m
230,48 m
299,82 m
309,42 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme